This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
In a move aimed at bolstering its molecular diagnostics portfolio and providing it with entry into the oncology testing arena, Qiagen said last weekend that it will acquire Digene in a cash and stock deal worth $1.6 billion.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.